Lumida
/DMRA
⌘K
DMRA

DMRA

DMRA
$28.10USD+4.69%+1.26 today

MARKET CAP

1.7B

P/E (TTM)

FWD P/E

DAY RANGE

$27 – $29

52W RANGE

$17
$35

AI Summary

Stalk
TrimMedium

DMRA has decisively broken below key support zones and all short-term EMAs, confirming continuation of the downtrend in a Stage 4 distribution phase. The primary Support Failure pattern grants medium-term permission for bearish engagement, but the oversold context and a recent relief bounce suggest short-term relief rallies may occur. Execution should be deferred until rallies into the 9-day or 20-day EMA offer clear rejection opportunities. A sustained reclaim of broken support or a close above the EMAs with follow-through would invalidate the current bearish stance.

  • TD Cowen upgraded DMRA to strong-buy with a $44 price target
  • Analyst revision trends are positive, hinting at upward EPS expectations
  • Negative earnings yield and weak profitability hamper valuation
Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY3.16 M82.25 M+2.94 M+1327.6%0.00%
RC

Ra Capital Management, L.P.

Q2 2026

BUY2.40 M62.42 M+392.00+0.4%0.54%
JH

Janus Henderson Group Plc

Q1 2026

BUYNEW2.36 M61.44 M+2.36 M+0.0%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

BUYNEW2.06 M49.85 M+2.06 M+0.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL1.23 M31.97 M+-218.87 K-14.8%0.04%
PA

Perceptive Advisors LLC

Q2 2026

SELL1.22 M31.81 M+-1.22 M-49.8%0.48%
AC

Adar1 Capital Management, LLC

Q2 2026

BUY280.00 K7.28 M+1.00 K+0.8%0.34%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW166.35 K4.33 M+166.35 K+0.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL48.75 K1.27 M+-1.14 M-95.9%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-471.65 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-55.23 K-100.0%0.00%